Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A.
BACKGROUND: A proportion of men with prostate cancer will progress to develop metastatic disease involving the lymph-nodes and bone. To identify novel candidates associated with metastatic progression, we compared the proteomic profiles of LNCaP (lymph-node metastatic, androgen-dependant) and PC-3 (...
Main Authors: | Leiblich, A, Cross, S, Catto, J, Pesce, G, Hamdy, F, Rehman, I |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
Changes in the Cutaneous Nerve Fiber Staining and Distribution of PGP9.5 in Clinically Uninvolved Skin in Leprosy Patients after Completion of Multidrug Therapy and Assessing PGP9.5 as a Marker of Treatment Response
by: Vishal Thakur, et al.
Published: (2024-06-01) -
PGP 9.5- immunoreactivity in the ovary at different stages of oestrous cycle in rats
by: Ganabadi, Shanthi, et al.
Published: (2020) -
Analysis of OCT4 and PGP9.5 gene expression in prenatal and postnatal buffalo (Bubalus bubalis) testes
by: Ashritha Q. Carlo, et al.
Published: (2024-12-01) -
Expression and significance of Ninj1, IL-1β and PGP-9.5 in ectopic endometrial tissues of patients with endometriosis
by: ZHAO Li, LI Yuying, WANG Lei, JIAO Jinwen, SUN qi, HUANG Meisha, YUAN Fang
Published: (2024-10-01) -
CHROMOGRANIN-A IN THE DIAGNOSIS OF PROSTATE CANCER
by: A. V. Sivkov, et al.
Published: (2015-04-01)